Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.8 USD | +1.59% | -0.01% | +6.17% |
May. 28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
May. 28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
Official Publications
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
SEC Filing 8K | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Official Publications